^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    methylprednisolone acetate

    Associations

    News

    Trials
    Company:
    Generic mfg.
    Drug class:
    GCR agonist
    Related drugs:
    Associations

    News

    Trials
    1m
    Assessment and Comparison of Efficacy of Intra-Articular PRP and Corticosteroid in First CMC Joint OA Treatment (clinicaltrials.gov)
    P4, N=60, Completed, Antalya Training and Research Hospital
    New P4 trial
    |
    methylprednisolone acetate
    1m
    Particulate Vs. Non-Particulate Steroid for Sacroiliac Joint Injection (clinicaltrials.gov)
    P4, N=230, Recruiting, University of New Mexico | Trial completion date: May 2025 --> May 2027 | Trial primary completion date: Jan 2025 --> Jan 2027
    Trial completion date • Trial primary completion date
    |
    dexamethasone • methylprednisolone acetate
    2ms
    Conservative Treatment in Patients with Supraspinatus Tendon Injury. (clinicaltrials.gov)
    P=N/A, N=40, Recruiting, Medical University of Lodz
    New trial
    |
    BDNF (Brain Derived Neurotrophic Factor)
    |
    methylprednisolone acetate
    4ms
    ACP Max™ PRP System for Knee Osteoarthritis: A Feasibility Trial (clinicaltrials.gov)
    P=N/A, N=45, Recruiting, Arthrex, Inc. | Not yet recruiting --> Recruiting
    Enrollment open
    |
    methylprednisolone acetate
    5ms
    Comparison Between Platelet-rich Fibrin and Steroid for Intra-articular Injection for Sacroiliac Joint Dysfunction (clinicaltrials.gov)
    P4, N=94, Completed, Fayoum University Hospital | Recruiting --> Completed
    Trial completion
    |
    methylprednisolone acetate
    8ms
    Lumbar Steroid Use in Patients Undergoing Posterior Lumbar Decompression (clinicaltrials.gov)
    P3, N=150, Recruiting, Hospital for Special Surgery, New York | Trial primary completion date: Dec 2023 --> Dec 2024
    Trial primary completion date
    |
    methylprednisolone acetate
    8ms
    Particulate vs. Non-Particulate Steroid for Sacroiliac Joint Injection (clinicaltrials.gov)
    P4, N=230, Recruiting, University of New Mexico | Not yet recruiting --> Recruiting
    Enrollment open
    |
    dexamethasone • methylprednisolone acetate
    8ms
    Yale SEVEN: Yale Steroid Enhanced Versus Exparel Nerveblock TKA RCT Study (clinicaltrials.gov)
    P2, N=250, Recruiting, Yale University | Trial completion date: Dec 2024 --> Mar 2026 | Trial primary completion date: Apr 2024 --> Mar 2025
    Trial completion date • Trial primary completion date
    |
    dexamethasone • methylprednisolone acetate
    8ms
    ECOG-ACRIN-EAQ172: Infliximab and Intravenous Immunoglobulin Therapy in Treating Patients With Steroid-Refractory Pneumonitis (clinicaltrials.gov)
    P2, N=1, Terminated, ECOG-ACRIN Cancer Research Group | Trial completion date: Jul 2025 --> Dec 2023 | Active, not recruiting --> Terminated | Trial primary completion date: Jul 2025 --> Dec 2023; Slow accrual
    Trial completion date • Trial termination • Trial primary completion date • IO biomarker
    |
    prednisone • methylprednisolone acetate
    9ms
    Methylprednisolone Injections Treating Birch Pollen Induced Allergic Rhinitis. (clinicaltrials.gov)
    P4, N=44, Completed, Karolinska Institutet | Active, not recruiting --> Completed
    Trial completion
    |
    methylprednisolone acetate • methylprednisolone sodium succinate
    9ms
    Adhesive Capsulitis: Prospective Analysis of Efficacy and Financial Impact for Use of Physical Therapy in Treatment (clinicaltrials.gov)
    P4, N=260, Recruiting, Massachusetts General Hospital | Trial completion date: Dec 2025 --> Dec 2027 | Trial primary completion date: Dec 2024 --> Dec 2026
    Trial completion date • Trial primary completion date
    |
    methylprednisolone acetate
    9ms
    Particulate vs. Non-Particulate Steroid for Sacroiliac Joint Injection (clinicaltrials.gov)
    P4, N=230, Not yet recruiting, University of New Mexico
    New P4 trial
    |
    methylprednisolone acetate
    9ms
    The Effects of Acthar on Synovial Inflammation in Rheumatoid Arthritis (clinicaltrials.gov)
    P3, N=6, Active, not recruiting, Attune Health Research, Inc. | Trial completion date: Dec 2023 --> Dec 2024
    Trial completion date
    |
    methylprednisolone acetate
    10ms
    Ultrasound Guided Platelet Rich Plasma Injections for Post Traumatic Greater Occipital Neuralgia (clinicaltrials.gov)
    P1, N=35, Completed, University of Calgary | Active, not recruiting --> Completed
    Trial completion
    |
    methylprednisolone acetate
    10ms
    Adductor Canal Block With Periarticular Injection and IPACK (ACB/PAI/IPACK) Versus Periarticular Injection (PAI) (clinicaltrials.gov)
    P4, N=86, Completed, Hospital for Special Surgery, New York | Phase classification: P=N/A --> P4 | Unknown status --> Completed
    Trial completion • Phase classification
    |
    dexamethasone injection • methylprednisolone acetate
    10ms
    Pilot Study Using Changes in Serum BCMA to Determine Disease Progression in Multiple Myeloma (clinicaltrials.gov)
    P1, N=30, Not yet recruiting, Oncotherapeutics
    New P1 trial
    |
    lenalidomide • Jakafi (ruxolitinib) • methylprednisolone acetate
    11ms
    ACP Max™ PRP System for Knee Osteoarthritis: A Feasibility Trial (clinicaltrials.gov)
    P=N/A, N=45, Not yet recruiting, Arthrex, Inc. | Trial completion date: Aug 2025 --> Feb 2026 | Initiation date: Aug 2023 --> Feb 2024 | Trial primary completion date: Aug 2024 --> Feb 2025
    Trial completion date • Trial initiation date • Trial primary completion date
    |
    methylprednisolone acetate
    1year
    Weekly 70 mg/m2 Carfilzomib for Multiple Myeloma Patients Refractory to 27 mg/m2 Carfilzomib (clinicaltrials.gov)
    P2, N=45, Terminated, Oncotherapeutics | Unknown status --> Terminated; Early termination due to the difficulties to enroll subjects.
    Trial termination
    |
    lenalidomide • prednisone • carfilzomib • pomalidomide • dexamethasone injection • methylprednisolone acetate • methylprednisolone sodium succinate
    1year
    A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients (clinicaltrials.gov)
    P1, N=134, Recruiting, Oncotherapeutics | Trial primary completion date: Sep 2022 --> Sep 2024
    Trial primary completion date
    |
    lenalidomide • Jakafi (ruxolitinib) • melphalan • methylprednisolone acetate • methylprednisolone oral
    1year
    Ultrasound Guided Platelet Rich Plasma Injections for Post Traumatic Greater Occipital Neuralgia (clinicaltrials.gov)
    P1, N=35, Active, not recruiting, University of Calgary | Trial completion date: May 2023 --> Dec 2023
    Trial completion date
    |
    methylprednisolone acetate